How Much Does Oral Micronized Progesterone Cost in Alaska?

Alaska Cash-Pay Prices for Oral Micronized Progesterone in 2026

The average retail cash price for generic oral micronized progesterone at Alaska pharmacies sits around $45 per month in 2026. That figure covers a standard 30-capsule supply of 100 mg or 200 mg capsules taken nightly. Brand-name Prometrium carries a manufacturer list price of roughly $180 per month, though very few patients pay that full amount.

Alaska's pharmacy market is concentrated. Roughly 70% of prescriptions in the state fill through chain pharmacies (Fred Meyer, Walmart, Safeway) clustered in Anchorage, Fairbanks, and Juneau, with independent pharmacies serving smaller communities and rural areas. Prices vary by retailer and location. A Walmart in Anchorage may price generic progesterone at $35 for a 30-day supply, while a rural independent pharmacy in Bethel or Nome could charge $55 or more due to higher operating and shipping costs. The FDA approved oral micronized progesterone (brand name Prometrium, manufactured by Solvay/AbbVie) for use in combination with conjugated estrogens in postmenopausal women with an intact uterus, based on data from the PEPI trial (JAMA 1995) and subsequent studies [1]. That trial enrolled 875 postmenopausal women and demonstrated that micronized progesterone provided endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile. Generics entered the market after patent expiration, driving cash prices well below the brand.

Patients filling without insurance should always ask the pharmacy for the "cash price" rather than running the prescription through a defunct or high-deductible plan, as the cash price is sometimes lower than the insurance-adjudicated price.

Does Alaska Medicaid Cover Oral Micronized Progesterone?

Alaska Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection as part of hormone replacement therapy. This gap affects a meaningful number of Alaskans. As of 2025, approximately 240,000 Alaskans were enrolled in Medicaid or the Children's Health Insurance Program, accounting for roughly one-third of the state's population according to CMS enrollment data.

The non-coverage designation applies specifically to the HRT indication. Medicaid formulary decisions in Alaska are managed through the state's preferred drug list, and oral micronized progesterone has not been added for the HRT use case. If a prescriber documents an alternative clinical indication (such as luteal phase support in fertility treatment), coverage may be adjudicated differently. Prior authorization requests for off-formulary coverage remain an option, though approval rates for this specific drug-indication pair in Alaska have not been publicly reported.

For Medicaid beneficiaries who need progesterone for endometrial protection, the compounded route at $25 per month (discussed below) or manufacturer assistance programs may offer more affordable access than paying cash for the branded or generic product.

Compounded Progesterone in Alaska: Legal and Available

Compounded oral micronized progesterone is legal in Alaska through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and federal guidelines established by the FDA under Section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy compounds medications based on individual patient prescriptions, not in bulk for general distribution.

Alaska has several licensed compounding pharmacies, primarily in Anchorage. Patients in remote areas can often receive compounded medications by mail within the state, as Alaska law permits shipment of compounded prescriptions to patients with valid prescriptions. The typical cost for compounded oral micronized progesterone runs about $25 per month, roughly 45% less than the generic retail price.

One caution applies. Compounded progesterone is not FDA-approved, and it does not carry the same bioequivalence testing or manufacturing oversight as FDA-approved generics. The Endocrine Society and the American College of Obstetricians and Gynecologists (ACOG) have both issued statements recommending FDA-approved hormone products over compounded versions when an FDA-approved option exists and is accessible [2]. Dr. JoAnn Manson, professor of medicine at Harvard Medical School and lead investigator of the Women's Health Initiative hormone therapy trials, has stated: "FDA-approved formulations should be the first choice because they have undergone rigorous testing for potency, purity, and consistency." Compounding remains a reasonable fallback for patients with specific allergies to inactive ingredients in commercial formulations or for those who face genuine cost barriers.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans available in Alaska cover generic oral micronized progesterone, typically placing it on Tier 1 or Tier 2 of their formularies. Here is what the major payers look like.

Premera Blue Cross Blue Shield of Alaska, the largest commercial insurer in the state, lists generic micronized progesterone on its preferred formulary with a standard Tier 1 copay (usually $10 to $15 for a 30-day supply). Brand Prometrium falls on Tier 3, carrying a higher copay of $40 to $60 depending on the specific plan.

Moda Health, which offers plans on the Alaska individual marketplace, covers generic progesterone with prior authorization not required for the standard HRT indication. Copays range from $10 to $20.

Federal employee plans (FEHB) used by the substantial federal workforce in Alaska (military, Coast Guard, federal agencies) generally cover oral micronized progesterone. GEHA and Blue Cross Blue Shield Federal plans both list it as a covered generic.

Tricare, relevant to Alaska's large active-duty and veteran population, covers oral micronized progesterone at military pharmacies with a $0 copay for the generic and $14 for brand Prometrium through the Tricare Pharmacy Home Delivery program [3].

Patients should verify their specific plan's formulary before assuming coverage. The PEPI trial established micronized progesterone as a standard of care for endometrial protection in women on estrogen therapy, and this clinical evidence base generally supports coverage decisions across commercial payers [1].

Telehealth Prescribing: How It Works in Alaska

Alaska permits telehealth prescribing of oral micronized progesterone. The state adopted broad telehealth parity legislation, and the Alaska State Medical Board allows prescribers to establish patient-provider relationships via synchronous video or audio visits. No in-person visit is required before a progesterone prescription can be written.

This is particularly relevant for Alaska. Roughly half the state's population lives outside the Anchorage metro area, and many communities lack local OB-GYN or endocrinology providers. Women in Kodiak, Sitka, the Matanuska-Susitna Valley, or the North Slope can consult with a licensed prescriber via telehealth and receive a prescription sent to their local pharmacy or a mail-order pharmacy.

HealthRX offers telehealth consultations for hormone therapy, including oral micronized progesterone, with prescriptions sent to the patient's preferred pharmacy. The process typically involves a medical intake, provider review, and prescription issuance within 24 to 48 hours. Lab work (typically a basic metabolic panel and hormone levels) may be ordered before or shortly after initiation, depending on clinical context and the prescriber's assessment.

The North American Menopause Society (NAMS) supports telehealth as an appropriate modality for initiating and managing hormone therapy in menopausal women, noting that it can improve access in underserved areas [4].

How to Get the Lowest Price in Alaska

Several strategies can reduce out-of-pocket costs for oral micronized progesterone in Alaska.

Use a generic. The simplest step. Generic micronized progesterone capsules are therapeutically equivalent to brand Prometrium and cost 75% less at retail.

Compare pharmacy prices. A five-minute phone call to two or three pharmacies can reveal price differences of $10 to $20 for the same generic drug. GoodRx and RxSaver coupons can bring the price at participating Alaska pharmacies to as low as $15 to $25 for a 30-day supply, though availability of these discount prices varies by location.

Consider compounding. At $25 per month, a licensed 503A compounding pharmacy offers the lowest per-unit cost. Patients should confirm that the compounding pharmacy is licensed by the Alaska Board of Pharmacy and follows USP 795 standards for non-sterile compounding.

Manufacturer savings cards. AbbVie (which markets Prometrium) offers a savings card program that can reduce the cost of brand Prometrium to $25 or less per fill for commercially insured patients. The card does not apply to government insurance (Medicaid, Medicare Part D, Tricare). Patients can check eligibility and enroll through the Prometrium website or by asking their pharmacy.

90-day fills. Many insurers and discount programs offer lower per-unit pricing for 90-day supplies. If a patient's plan allows it, a 90-day fill of generic progesterone can reduce the effective monthly cost by 15% to 25%.

Patient assistance programs. For uninsured patients, NeedyMeds and RxAssist maintain databases of patient assistance programs that may cover progesterone. AbbVie's patient assistance program covers brand Prometrium for qualifying uninsured patients with household incomes below 200% of the federal poverty level.

Clinical Context: Why Progesterone Matters on HRT

Oral micronized progesterone is not optional for women with a uterus who take estrogen therapy. Unopposed estrogen increases endometrial cancer risk by 2- to 10-fold depending on dose and duration, according to data reviewed by the National Cancer Institute [5]. Adding a progestogen eliminates this excess risk.

The PEPI trial (N=875) demonstrated that oral micronized progesterone at 200 mg per day for 12 days per month provided endometrial protection equivalent to medroxyprogesterone acetate 10 mg, while producing significantly better effects on HDL cholesterol [1]. Specifically, the micronized progesterone group saw a 4.1 mg/dL increase in HDL over three years, compared to a 1.2 mg/dL decrease in the medroxyprogesterone group.

The 2022 Hormone Therapy Position Statement from NAMS explicitly lists micronized progesterone as a preferred progestogen option, noting its favorable cardiovascular and breast safety profile relative to synthetic progestins [4]. A 2020 meta-analysis published in the BMJ found that micronized progesterone was associated with a lower breast cancer risk compared to synthetic progestins when used as part of combined HRT [6].

Standard dosing follows one of two patterns: continuous (100 mg nightly) or cyclic (200 mg nightly for 12 to 14 days per calendar month). The choice depends on whether the patient is in early menopause (where cyclic dosing may be preferred to produce a withdrawal bleed) or late menopause (where continuous dosing avoids monthly bleeding). The ACOG Practice Bulletin on hormone therapy provides guidance on selecting the appropriate regimen [2].

Prometrium vs. Generic vs. Compounded: A Cost Comparison

The table below summarizes the three main options available to Alaska patients in 2026.

| Option | Approximate Monthly Cost | FDA-Approved | Insurance Typically Covers | |---|---|---|---| | Brand Prometrium | $180 (list); $25-60 with insurance | Yes | Yes (Tier 3) | | Generic micronized progesterone | $45 cash; $10-20 with insurance | Yes | Yes (Tier 1-2) | | Compounded (503A) | $25 cash | No | Rarely |

For most patients with commercial insurance, the generic version with a Tier 1 copay represents the best value. For uninsured patients, compounded progesterone at $25 per month or a discount coupon bringing generic to $15-25 offers the most affordable path. Brand Prometrium makes financial sense only when a manufacturer savings card brings the copay below the generic price, which occasionally happens with certain high-deductible plans.